“…To date, a myriad of assays have been developed for antibody detection and measurement, including lateral flow assays, , enzyme-linked immunosorbent assay (ELISA), , and immunoaffinity chromatography. , These, however, differ widely in terms of duration (from minutes to hours), performance (sensitivity, limit of detection, and dynamic range), and cost. Likewise, the biorecognition moieties utilized to target the antibody analyte include protein-based affinity tags such as antigens, secondary antibodies, and antibody-binding receptors (e.g., Protein A, Protein G, and Fc receptors FcγRs), as well as synthetic affinity tags such as aptamers and peptides. − Finally, detection modalities vary significantly ranging from optical (e.g., UV/vis, fluorescence, and surface plasmon resonance) , to electrochemical (e.g., impedance and amperometry) and acoustic (e.g., photoacoustic and quartz crystal microbalance) . Fluorescence holds a preeminent place among detection modalities, owing to its high sensitivity, flexibility, and availability of fluorescence spectrophotometers. , The generation of a fluorescence signal by the affinity tags can be accomplished either by chemical conjugation, i.e., by labeling them with synthetic fluorophores, or enzymatically by fusing them with enzymes (e.g., horseradish peroxidase or luciferase) that convert substrates into fluorescent products. , Of major interest are combinations of fluorophores and labeling strategies that can engage in phenomena such as static or dynamic quenching. − Such combinations of fluorophores and labeling strategies enable continuous monitoring of the titer of analytes as their concentration evolves with time and provides information regarding the biomolecular structure of the analyte–tag complex …”